The phase 3 NRG Oncology GU005 trial tested SBRT vs MH-IMRT radiation for intermediate-risk prostate cancer for disease control and quality of life.

Despite SBRT (radiation) to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.

CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.

Immunocompromised status may negatively affect survival outcomes in patients with bladder cancer, a study suggests.

Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...

Author says findings support previous clinical trial data showing efficacy of baricitinib in preserving beta cell function in T1D.

41 percent of practices declined to schedule appointment for hypothetical patient weighing 465 lb; 52 percent lacked basic standards of care.

Survival rates also are lower for Black versus White people across various cancer types and categories of urbanicity.

Adverse cardiovascular outcomes and mortality risks were higher among patients with type 1 diabetes relative to type 2 ...

Active LN and the presence of U1-RNP antibodies were linked to low BMD and osteoporosis among patients with SLE.

Topline results were announced from a phase 3 head-to-head study comparing orforglipron with oral semaglutide in adults with ...

(HealthDay News) — Progress in cancer research, including approval of 20 new anticancer therapeutics in the past year, is ...